• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

P7C:GR

0.290 EUR 0.013 4.69%

As of 02:05:27 ET on 04/17/2014.

Snapshot for Aqualis ASA (P7C)

Open: 0.269 Day's Range: 0.269 - 0.290 Volume: 0
Previous Close: 0.277 52wk Range: 0.141 - 0.395 1-Yr Rtn: +86.59%

Stock Chart for P7C

No chart data available.
  • P7C:GR 0.290
  • 1D
  • 1M
  • 1Y
0.277
Interactive P7C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for P7C

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 39.9818
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) 0.0600
Est. PEG Ratio -
Market Cap (M EUR) 40.77
Shares Outstanding (M) 140.59
30 Day Average Volume 487
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for P7C

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for P7C

Aqualis ASA is a biopharmaceutical research company. The Company develops pharmaceuticals for the treatment of cancer.

Martin NesInterim ChairmanGeir StormorkenDeputy Chairman
Gunnar ManumActing CEO/CFOOle Henrik EriksenChief Business Officer/Founder
More Company Profile & Key Executives for P7C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil